Tag: Artivion
Full IDE dataset from AMDS PRESERVE trial presented at STS 2025
Artivion has announced data from the AMDS PERSEVERE clinical trial presented in a late-breaking science presentation at the Society of Thoracic Surgeons (STS) 2025...
Artivion granted US FDA humanitarian device exemption for the AMDS hybrid...
Artivion recently announced that the US Food and Drug Administration (FDA) has granted a humanitarian device exemption (HDE) for use of the AMDS hybrid...
Vascular News’ top 10 most popular stories of July 2024
Several company updates including Series A funding for Endoron Medical, new insights on the role of machine learning in determining endovascular aneurysm repair (EVAR)...
Artivion amends agreements with Endospan
Artivion recently announced it has amended its credit facility and option purchase agreements with Endospan, developer of the Nexus stent graft system. In 2019,...
Artivion announces meaningful all-cause mortality reduction in AMDS PERSEVERE trial
Artivion has announced presentation of interim results from the Ascyrus medical dissection stent (AMDS) PERSEVERE clinical trial in a late-breaking science session at the...
Trusted together: AAA treatment with E-tegra and E-liac
This educational supplement, sponsored by Artivion, is only available in selected countries and geographies.
The E-liac stent graft system (Artivion/Jotec), according to the clinical...
Iliac side branch devices a “gamechanger” in AAA treatment
NOTE: This video is ONLY available to watch in selected countries and geographies
Iliac side branch devices (ISBs) are “gamechangers in infrarenal therapy of...
Demand for “widely applicable” inner branch technology set to increase as...
NOTE: This video is ONLY available to watch in selected countries and geographies
Said Abisi (London, UK) discusses inner branched endovascular aneurysm repair (iBEVAR)...
Artivion initiates enrolment in PERSEVERE clinical trial
Artivion announced today that it has initiated enrolment in the PERSEVERE clinical trial to determine if patients with an acute DeBakey Type I aortic...
CryoLife announces corporate rebranding and changes name to Artivion
CryoLife announced that it was renaming and rebranding itself to Artivion, effective immediately. Derived from the words "aorta", "innovation", and "vision", the company's new...
